We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
Cap. Flow
-$2.79B
Cap. Flow %
-20.16%
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$66.4M
2
VLO icon
Valero Energy
VLO
+$28.9M
3
SLB icon
SLB Ltd
SLB
+$24.8M
4
BNY
Bank of New York Mellon
BNY
+$22.6M
5
PEP icon
PepsiCo
PEP
+$20.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$182M
2
AAPL icon
Apple
AAPL
+$148M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.9M
4
AMGN icon
Amgen
AMGN
+$72.1M
5
TSLA icon
Tesla
TSLA
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.26%
2 Technology 28.78%
3 Financials 8.15%
4 Consumer Discretionary 7.54%
5 Industrials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAL icon
451
Halliburton
HAL
$26.5B
$2.33M 0.02%
70,703
-1,356
-2% -$42.8K
EWTX icon
452
Edgewise Therapeutics
EWTX
$4.38B
$2.31M 0.02%
298,000
– –
RARE icon
453
Ultragenyx Pharmaceutical
RARE
$2.54B
$2.28M 0.02%
49,480
-11,155
-18% -$517K
AGCO icon
454
AGCO
AGCO
$8.95B
$2.27M 0.02%
17,304
+1,440
+9% +$179K
CTSH icon
455
Cognizant
CTSH
$23.6B
$2.21M 0.02%
33,925
-143,579
-81% -$8.89M
U icon
456
Unity
U
$13B
$2.19M 0.02%
50,421
-7,256
-13% -$232K
PHR icon
457
Phreesia
PHR
$660M
$2.17M 0.02%
+70,000
New +$2.19M
LUV icon
458
Southwest Airlines
LUV
$22B
$2.14M 0.02%
+59,232
New +$1.86M
PLNT icon
459
Planet Fitness
PLNT
$4.35B
$2.14M 0.02%
31,707
-9,647
-23% -$692K
CLX icon
460
Clorox
CLX
$12.1B
$2.12M 0.02%
13,336
-6,451
-33% -$1.04M
CNI icon
461
Canadian National Railway
CNI
$78.2B
$2.12M 0.02%
17,458
-10,101
-37% -$1.2M
HUBB icon
462
Hubbell
HUBB
$26.1B
$2.12M 0.02%
6,381
-4,754
-43% -$1.32M
HDB icon
463
HDFC Bank
HDB
$121B
$2.09M 0.02%
60,000
-22,000
-27% -$742K
BR icon
464
Broadridge
BR
$18.4B
$2.08M 0.02%
12,545
-6,263
-33% -$948K
CVX icon
465
Chevron
CVX
$381B
$2.08M 0.02%
13,197
-1,843
-12% -$295K
KKR icon
466
KKR & Co
KKR
$91.7B
$2.07M 0.02%
36,992
-31,157
-46% -$1.63M
MNST icon
467
Monster Beverage
MNST
$96.3B
$2.06M 0.01%
35,834
-8,057
-18% -$458K
VRSN icon
468
VeriSign
VRSN
$25.6B
$2.05M 0.01%
9,091
-6,060
-40% -$1.34M
SBAC icon
469
SBA Communications
SBAC
$19.1B
$2.05M 0.01%
8,851
-6,531
-42% -$1.56M
AKYA
470
DELISTED
Akoya BioSciences
AKYA
$2.04M 0.01%
276,300
+20,000
+8% +$134K
DLR icon
471
Digital Realty Trust
DLR
$72.3B
$2.03M 0.01%
17,836
-17,056
-49% -$1.69M
SE icon
472
Sea Limited
SE
$63.4B
$2.02M 0.01%
34,860
+13,991
+67% +$998K
LRN icon
473
Stride
LRN
$3.93B
$2.02M 0.01%
54,142
– –
ZS icon
474
Zscaler
ZS
$23.3B
$2.01M 0.01%
13,737
-10,873
-44% -$1.33M
NOMD icon
475
Nomad Foods
NOMD
$1.7B
$2M 0.01%
114,338
+23,022
+25% +$419K
17 18
19
20 21

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2023 Portfolio in Review

As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.

  • Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
  • Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
  • Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
  • Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
  • Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
  • Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.